Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | Grant Details | GRANTED
National Institutes of Health
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
Full grant description and program details are available when you create an account. Sign up to access eligibility criteria, requirements, and application instructions.